Unraveling the pathophysiological role of alpha-synuclein aggregation, transmission and neuroinflammation in neurodegeneration. KU Leuven
To date, Parkinsons Disease (PD) cannot be cured, instead therapy is directed at alleviating symptoms. A major challenge for the future is therefore the development of disease modifying therapies which halt, or at least slow down, disease progression. Since the identification of genetic factors as a cause of PD, our understanding of pathogenic
mechanisms involved in PD pathogenesis has increased tremendously. In addition, these studies ...